ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Hemophilia A or B with Inhibitors with or without Prophylactic Treatment

Author(s):
Michael Callaghan, W Allen Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Miguel Escobar, Adam Giermasz, Nikki Hirsh, Janna Journeycake, Sonia Nasr, Doris Quon, Tammuella Chrisentery-Singleton, Michael Recht
Publication:
Haemophilia
Date:
July 1, 2022
Topics:
Safety, Eptacog-Beta

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.